Does Wegovy Cause Ovarian Cysts? Evidence, Risks and Guidance

Current evidence does not show a proven link between Wegovy and ovarian cysts, although weight loss and hormonal changes may affect periods and ovarian function.

Does Wegovy Cause Ovarian Cysts? Evidence, Risks and Guidance

Starting Wegovy can bring noticeable changes beyond the number on the scales. If pelvic discomfort, altered periods or unfamiliar reproductive symptoms appear during treatment, it is natural to wonder whether the Wegovy injection could be affecting the ovaries or contributing to cyst formation.

So far, available safety information has not identified ovarian cysts as an established concern with Wegovy, although reproductive symptoms during treatment may still need individual assessment. However, reproductive symptoms can have many causes, which makes context important. This guide explores what current evidence tells us, where uncertainty remains, and which symptoms should prompt medical assessment.

GLP-1

Wegovy

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
  • βœ” ~16.9% average body weight loss
  • βœ” Boosts metabolic & cardiovascular health
  • βœ” Proven, long-established safety profile
  • βœ” Weekly injection, easy to use

Key Facts About Wegovy and Ovarian Cysts

  • Research has not established ovarian cysts as a side effect of Wegovy.
  • Current evidence does not show that Wegovy causes ovarian cysts.
  • Ovarian cysts are not recognised among established Wegovy side effects.
  • Weight loss may influence periods, ovulation and reproductive hormones.
  • PCOS-related follicles are different from typical ovarian cysts.
  • Bloating and abdominal discomfort can overlap with Wegovy-related digestive effects.
  • Persistent, unusual or severe pelvic symptoms should be medically assessed.

Does Wegovy Cause Ovarian Cysts? What the Evidence Shows

Current evidence does not show that Wegovy causes ovarian cysts. Ovarian cysts are not recognised among established Wegovy injection side effects, and no causal link with semaglutide has been confirmed.

Clinical and Regulatory Evidence

Clinical trials and safety information from the MHRA and EMA do not list ovarian cysts as a recognised adverse effect of Wegovy. This regulatory evidence helps distinguish an event occurring during treatment from an adverse effect proven to result from the medicine.

Weight Loss and Hormonal Changes

Significant weight loss can affect oestrogen levels, ovulation and menstrual regularity. These changes may sometimes cause reproductive symptoms that create concern about Wegovy and ovarian cysts, but they are not evidence of direct cyst formation.

PCOS and Ovarian Function

In people with PCOS, weight loss and improved insulin sensitivity may support more regular ovulation and menstrual cycles. PCOS is also different from ordinary ovarian cysts, as the small follicles associated with the condition are not the same as functional cysts.

Reports Versus Proven Side Effects

Some people may discover ovarian cysts while taking GLP-1 medicines, but correlation does not establish causation. Functional ovarian cysts are common and often occur independently of medication.

Persistent pelvic pain, unusual bleeding or other reproductive changes should therefore be assessed rather than automatically attributed to the weight loss injection Wegovy.

How Wegovy May Affect Hormones, Periods and PCOS

Wegovy does not directly regulate reproductive hormones, but the weight loss and metabolic changes associated with treatment can influence menstrual patterns and ovarian function. Changes in body fat, insulin sensitivity and energy balance may affect the hormonal signals involved in ovulation, particularly when weight loss is substantial.

Period and Hormonal Changes

Body fat plays a role in oestrogen metabolism, so meaningful weight loss can sometimes coincide with changes in cycle timing, flow or regularity. These shifts may be temporary and do not mean the Wegovy injection is causing ovarian cysts.

Wegovy and PCOS

PCOS is commonly associated with insulin resistance, higher androgen levels and irregular ovulation. GLP-1 medicines can support weight loss and metabolic improvement, and studies of semaglutide have reported improvements in insulin resistance and menstrual regularity in some people with PCOS. However, the evidence remains limited and results vary between studies.

Improved insulin sensitivity may also reduce some of the metabolic drivers linked with excess androgen activity, which could help explain why periods or ovulation become more regular during weight loss. This is different from saying Wegovy directly treats ovarian cysts.

Wegovy Is Not an Approved PCOS Treatment

Wegovy is licensed for weight management, not specifically for PCOS or ovarian cysts. Although improving weight and metabolic health may positively affect reproductive symptoms in some people with PCOS, it should not be viewed as a direct treatment for either condition.

These metabolic changes may therefore help explain why menstrual patterns or ovulation can shift during weight loss treatment.

Ovarian Cysts vs Wegovy Side Effects: What Symptoms Should You Look For?

Digestive symptoms during Wegovy treatment can sometimes overlap with symptoms associated with ovarian conditions. Looking at the location, pattern and accompanying symptoms can help distinguish between them.

Symptom Ovarian Cysts Wegovy Side Effects
Pelvic pain or pressure Dull ache, one-sided discomfort or pelvic pressure may occur Not usually pelvic-specific
Abdominal pain Possible, particularly with larger cysts Stomach or abdominal discomfort is common
Bloating or fullness May cause lower abdominal fullness or pressure Bloating and gas can occur
Menstrual changes Irregular periods or mid-cycle discomfort may occur Not a typical direct side effect, although weight loss may influence cycles
Nausea or vomiting Possible with rupture or ovarian torsion Nausea and vomiting are common, especially during dose escalation
Diarrhoea or constipation Constipation may occur from pelvic pressure; diarrhoea is less typical Both are common
Urinary pressure Larger cysts may increase the need to urinate Not a typical Wegovy effect
Fatigue, headache or dizziness Not characteristic cyst symptoms Can occur with Wegovy
No symptoms Many cysts are found incidentally on ultrasound Some people experience few or no adverse effects

Abdominal discomfort alone does not confirm an ovarian cyst. Persistent pelvic pressure, one-sided pain, menstrual changes or pain during intercourse deserve attention. Sudden or rapidly worsening pelvic symptoms may require prompt medical assessment. For less urgent concerns, an online consultation can help clarify symptoms and appropriate next steps.

Ovarian Cysts: Causes, Symptoms and Risk Factors

Ovarian cysts are fluid-filled sacs that form on or within an ovary. Many develop naturally during the menstrual cycle and resolve without treatment, while others are linked with conditions such as endometriosis or hormonal disorders.

What Causes Ovarian Cysts?

Functional cysts are the most common. Follicular cysts form when an egg is not released, while corpus luteum cysts may develop after ovulation. Other types include endometriomas, dermoid cysts and cystadenomas. PCOS is different from having a typical ovarian cyst. It is a hormonal and metabolic condition often associated with multiple small immature follicles.

Ovarian Cyst Symptoms

Some cysts cause no symptoms and are only discovered during an ultrasound. Possible ovarian cysts symptoms include one-sided pelvic pain, bloating, pain during intercourse, menstrual changes, urinary pressure and constipation.

Risk Factors and Complications

Risk factors include hormonal imbalance, previous ovarian cysts, endometriosis, pelvic infection and PCOS. These conditions can occur independently of Wegovy.

Most cysts are harmless, but complications such as cyst rupture or ovarian torsion can occasionally occur and may require urgent treatment. Ovarian cysts found after menopause also generally need closer evaluation.

What to Do if You Develop an Ovarian Cyst

If an ovarian cyst is found, treatment depends on its size, appearance, symptoms and whether you have reached menopause. Many simple cysts only need monitoring and a follow-up ultrasound, while persistent, large or symptomatic cysts may need specialist review.

If you are taking Wegovy, do not stop treatment solely because a cyst has been discovered unless your prescriber advises you to. Your clinician can determine whether monitoring, repeat imaging or specialist review is needed.

When to Seek Help for Pelvic Symptoms on Wegovy

Pelvic symptoms should not always be assumed to be related to Wegovy, especially if they are persistent, unusual or worsening.

Seek medical advice for:

  • ongoing or unexplained pelvic pain
  • new or significant menstrual changes
  • pain during sex
  • unusual vaginal bleeding
  • symptoms that keep returning or become more severe

Seek urgent medical help for sudden severe pelvic or abdominal pain with vomiting, dizziness, fainting or weakness, as this may indicate ovarian torsion or a ruptured cyst. A clinician can assess your symptoms, review your treatment and arrange a pelvic ultrasound or other tests if needed.

Conclusion: Wegovy and Ovarian Cysts

The available evidence remains reassuring, while also showing why reproductive symptoms during weight loss treatment need to be considered in context. Hormonal changes, PCOS and naturally occurring ovarian cysts can each affect periods or pelvic symptoms independently.

If you develop persistent pelvic pain, menstrual changes or other unusual reproductive symptoms while using the Wegovy injection, it is important to have them assessed rather than assuming they are treatment-related. London Slimming Clinic can support you with clinically supervised weight loss treatment and guidance on whether new symptoms may require further medical assessment, monitoring or referral.

GLP-1 / GIP

Mounjaro

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
  • βœ” ~22.5% average body weight loss
  • βœ” Significant weight reduction
  • βœ” Improves blood sugar levels
  • βœ” Clinically proven weight loss
GLP-1

Wegovy

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
  • βœ” ~16.9% average body weight loss
  • βœ” Boosts metabolic & cardiovascular health
  • βœ” Proven, long-established safety profile
  • βœ” Weekly injection, easy to use

FAQs About Wegovy and Ovarian Cysts

Most ovarian cysts do not affect fertility, especially functional cysts that resolve naturally. However, conditions linked with cysts, such as endometriosis, can sometimes make conception more difficult. If treatment is required, clinicians usually aim to preserve ovarian function wherever possible.

The direct effect of semaglutide on fertility is not fully established. Weight loss and improved metabolic health may influence ovulation, particularly in people with irregular cycles, but Wegovy is not a fertility treatment.

Wegovy should be stopped at least two months before a planned pregnancy because semaglutide remains in the body for several weeks. Speak with your prescriber before stopping or changing treatment.

Wegovy is not recommended during breastfeeding because there is insufficient evidence to confirm its safety for the baby. Treatment options and the appropriate time to restart semaglutide should be discussed with a healthcare professional.

Yes. A pelvic ultrasound can show the cyst’s size, location and appearance. Depending on the findings, your clinician may recommend monitoring, a repeat scan or further investigation.

Many functional ovarian cysts disappear naturally within a few months and need no treatment. Larger, persistent, symptomatic or unusual-looking cysts may require additional monitoring or specialist assessment.

Most ovarian cysts are benign. The risk of malignancy is generally higher after menopause, so suspicious or persistent cysts may require further scans, blood tests or referral to a gynaecology specialist.

Yes. New cysts can develop after a previous cyst has resolved or been treated, particularly functional cysts linked with ovulation. Recurrent cysts may sometimes warrant investigation for underlying conditions such as endometriosis or hormonal disorders.

Start Online Consultation

Your First Step Towards Safer Weight Loss Starts Here

VIEW ALL TREATMENTS